Tenoten tab. d / resorb. �40

The drug has a sedative, anti-anxiety (anxiolytic) effect, without causing undesirable hypnogenic and muscle relaxant effects.

Improves the tolerance of psycho-emotional stress.

Possesses stress-protective, nootropic, antiamnesic,

antihypoxic, neuroprotective, antiasthenic, antidepressant action.

In conditions of intoxication, hypoxia, in conditions after acute cerebrovascular accident, it has a neuroprotective

action, limits the area of ​​damage, normalizes learning and memory processes in the central nervous system (CNS).

Inhibits the processes of lipid peroxidation.

Modifies the functional activity of the S-100 protein, which carries out

in the brain, conjugation of synaptic (informational) and metabolic processes.

Providing GABA-mimetic and neurotrophic effects, it increases the activity of stress-limiting systems, helps to restore the processes of neuronal plasticity.

Name ENG

TENOTEN

Clinical and pharmacological group

Anxiolytic, nootropic drug

ATX code

Other anxiolytics, Other psychostimulants and nootropics

Dosage

3mg

Structure

Active ingredients: antibodies to brain-specific protein S-100 affinity purified - 0.003 * g. Excipients: lactose monohydrate (lactose) 0.267 g, microcrystalline cellulose 0.03 g, magnesium stearate 0.003 g * are applied to lactose in the form of a water-alcohol mixture with a content of not more than 10-15 ng / g of the active form of the active substance.

Indications

Neurotic and neurosis-like states, psychosomatic diseases

Stress disorders with increased nervous tension, irritability, anxiety and autonomic reactions

Moderately pronounced organic lesions of the central nervous system, incl.

traumatic and discirculatory origin, accompanied by instability of the emotional background, irritability, memory loss, autonomic disorders.

Contraindications

Increased individual sensitivity to the components of the drug, children under 18 years of age.

Lactase deficiency, lactose intolerance, glucose-galactose malabsorption.

INN / Active ingredient

antibodies to brain-specific protein S-100 affinity purified

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

40

Scope of application

Cardiology

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Shelf life after opening

3 months

Brand name

Materia Medica Holding

The amount of the dosage form in the primary package

20 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Nootropic agent

Anatomical and therapeutic characteristics

N06BX Other psychostimulants and nootropics

Dosage form

Lozenges

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

0.003 g

Package weight, g

twenty

Mode of application

:

Inside, 1-2 tables.

at one time (keep in the mouth until completely dissolved) not during a meal.

Take 2 times a day

if necessary - up to 4 doses per day.

The course of treatment is 1–3 months

if necessary, the course of treatment can be extended up to 6 months or repeated after 1–2 months.